Diabetes

The AJMC^® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.

Latest News

GLP-1s - K KStock - stock.adobe.com.jpeg

Eating Behaviors May Predict GLP-1 Therapy Success in Type 2 Diabetes

By Pearl Steinzor

September 18th 2025

A Japanese study links external eating patterns to weight loss and glycemic improvements with glucagon-like peptide-1 receptor agonists.

Diabetes monitoring | Image credit: andre - stock.adobe.com

Assessing the Rising Prevalence of Early-Onset Type 2 Diabetes in the US

By Pearl Steinzor

September 16th 2025

Carbohydrates | Image credit: EMB DESIGNER - stock.adobe.com

The Effects of White Potatoes vs White Rice on Type 2 Diabetes

By Pearl Steinzor

September 10th 2025

BMI obesity - Vitalii Vodolazskyi - AdobeStock_109782881.jpeg

GLP-1 RAs Linked to BMI-Dependent Heart Benefits in Type 2 Diabetes

By Pearl Steinzor

September 8th 2025

Woman laying on bed with mobile phone, using medical app | Prostock-studio - stock.adobe.com

Mobile Text Messages Improve Diabetes, Heart Risk Control

By Pearl Steinzor

September 2nd 2025

Advancing Care in Type 2 Diabetes and Obesity: A Coordinated, Guideline-Driven Approach

Understand how recent advances in GLP-1 receptor agonists and other therapies are transforming the treatment of type 2 diabetes and obesity through a shift of reactive to proactive care that addresses root causes of cardiometabolic disease.

Watch Now

Continuing Medical Education

View All

September 18th 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology

September 18th 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

More News

September 28th 2016

FDA Approves Medtronic's MiniMed 670G, 1st Hybrid Closed Loop System

Mary Caffrey

The company's announcement notably does not use the term "artificial pancreas," although the technology is a considerably more significant advance from the 530G threshold suspend device of 2013. When the description "artificial pancreas" was attached to that product, the term was met with howls of protest from the type 1 diabetes community.

September 27th 2016

Therapeutics Issue of Evidence-Based Diabetes Management Takes on Cost, Coverage, and Combinations

Whether it’s the high cost of insulin or the question of when to start combination therapy, the new issue of Evidence-Based Diabetes Management, a publication of The American Journal of Managed Care, covers up-to-the-minute topics in this special issue on therapeutics. Editor-in-chief Robert A. Gabbay, MD, PhD, FACP, leads off this issue featuring voices of providers, pharmaceutical leaders, payers, and patients.

September 27th 2016

Endocrine Society Endorses CGM as "Gold Standard" for Adults With Type 1 Diabetes

Mary Caffrey

The new guideline comes as FDA weighs an advisory panel recommendation for CGM dosing, which many see as a first step toward Medicare coverage.

September 26th 2016

Improving Global Health With Smarter City Planning

Laura Joszt, MA

A series of papers in The Lancet highlights how city planning and urban design can prevent chronic diseases and create healthier and more sustainable cities.

September 23rd 2016

Fitness Trackers May Not Bring Long-term Weight Loss, JAMA Study Finds

Mary Caffrey

Fitbits and other trackers are everywhere, but the study by JAMA finds that they may not help users with sustained weight loss, which has long eluded researchers.

September 23rd 2016

Mike Payne on Behavior Change and Modification in Diabetes Care

While Omada Health’s Prevent program is designed for individuals with prediabetes, it can be adapted to patients who already have diabetes, because the program is built on behavior change and modification, explained Mike Payne, MBA, MSci, former chief healthcare development officer at Omada Health.

September 21st 2016

Cardiovascular Disease and Workplace Stress

Mary Caffrey

While declining smoking rates have caused cardiovascular disease to decline overall, some risk factors are rising, such as hypertension, diabetes, and obesity.

September 21st 2016

When It Comes to Losing Weight, Genes Aren't the Whole Story

Mary Caffrey

The study in BMJ found that people with the FTO gene were just as likely to lose weight through interventions, such as diet, exercise, or therapy.

September 21st 2016

Cost-Benefit of Appointment-Based Medication Synchronization in Community Pharmacies

Julie A. Patterson, BS David A. Holdford, PhD, MS, BSPharm Kunal Saxena, PhD, MS

This study conducted a cost-benefit analysis of appointment-based medication synchronization for improving adherence in patients on chronic medications for hypertension, hyperlipidemia, and diabetes.

September 21st 2016

As Metformin Combinations Proliferate, Questions Arise About Value

Andrew Smith

For some patients newly diagnosed with type 2 diabetes, skipping metformin monotherapy and going straight to fixed-dose combinations with a DPP-4 inhibitor or an SGLT2 inhibitor makes sense, evidence shows.

September 20th 2016

Representativeness of Dipeptidyl-Peptidase-4 Inhibitor Cardiovascular Outcomes Trials

Joanna P. MacEwan, PhD John J Sheehan, PhD Anne Peters, MD Jacqueline Vanderpuye-Orgle, PhD Iftekhar Kalsekar, PhD Anup Malani, PhD

Given the growing prevalence of type 2 diabetes (T2D) and its contribution to cardiovascular disease, cardiovascular outcomes trials should aim to be more representative of the average patient with T2D.

September 20th 2016

NIH Study: Depression in Early Pregnancy Linked to Gestational Diabetes

Mary Caffrey

While obesity is a known risk factor in gestational diabetes, women who were obese and also were depressed when they became pregnant were at greater risk of gestational diabetes than those who did not have depression.

September 19th 2016

Sleep Disorders Linked to Heart Disease Risk in AHA Statement

Mary Caffrey

Evidence has been accumulating that links irregular sleep with chronic disease, but today is the first time the American Heart Association has issued a statement on the topic.

September 19th 2016

Intarcia Poised to Seek FDA Approval for ITCA 650 After Positive A1C, CV Results

Mary Caffrey

Officials say the company will file with FDA some time in the third quarter of 2016 to begin the approval process for the novel delivery system that brings a continuous, microscopic dose of exenatide to patients with type 2 diabetes.

September 16th 2016

Novo's Semaglutide Reduces CV Risk, but Shows More Retinopathy Complications

Mary Caffrey

Results for Novo Nordisk’s semaglutide were reported today at the European Association for the Study of Diabetes. A filing for FDA approval is expected before the end of the year.

September 16th 2016

In US, 28% of Adults Over 50 Get No Exercise

Mary Caffrey

The report showed a strong connection between states with high rates of inactivity and those with the highest rates of obesity.

September 16th 2016

5 Things to Know About Afrezza

Mary Caffrey

The current issue of Evidence-Based Diabetes Management explores studies and patient access issues surrounding this closely watched inhaled insulin.

September 16th 2016

Patients Report Barriers to Getting Afrezza, but A1C Results Are Worth It

Mary Caffrey

Gaining access to Afrezza can mean battling with an insurer to cover it. Sometimes the first hurdle is getting a doctor to write a prescription, according to those who've been through the process.

September 16th 2016

Afrezza: Treating Diabetes in a Physiologic Manner

R. Keith Campbell, MBA, BPharm, CDE

Professor R. Keith Campbell, MBA, BPharm, CDE, now retired from Washington State University College of Pharmacy, highlights the clinical advantages of Afrezza based on the evidence as well as his personal perspective.

September 15th 2016

Beverage Industry Sues Philadelphia to Block Soda Tax

Mary Caffrey

The suit doesn't address whether soda taxes have any effect on obesity or public health, but instead hinges on finer points of Pennsylvania tax law and its constitution.

September 15th 2016

Merck, Pfizer Announce Positive Results for Ertugliflozin

Mary Caffrey

Pfizer and Merck plan to file new drug applications with FDA for the SGLT2 inhibitor by the end of the year. One combination would pair ertugliflozin with Januvia, the blockbuster DPP-4 inhibitor.

September 14th 2016

Minorities, Southerners in Medicare Less Likely to Take High Blood Pressure Medication

Mary Caffrey

The authors said this is the first study to examine antihypertension nonadherence down to the county level. Recommendations include greater use of combination therapy to reduce pill counts for patients with multiple chronic conditions, and synchronizing pharmacy visits to avoid multiple trips.

September 13th 2016

Military's Problem With Obesity Getting Worse, Report Finds

Mary Caffrey

While the report found that the obesity rate among service members had gone up steadily since 2001, it was still only a fraction of the rate among the US population overall.

September 12th 2016

Lancet Publishes Results of Abbott's Flash Glucose Monitoring System

Mary Caffrey

The trial showed use of the flash glucose monitoring system dramatically reduced the number of finger sticks while significantly reducing hypoglycemia, including at night.

September 12th 2016

What We're Reading: Clinton Has Pneumonia, Raising New Speculation About Her Health

AJMC Staff

What we're reading, September 12, 2016: Hillary Clinton's health is being called into question as her campaign confirms she has pneumonia; responders who helped during the 9/11 terrorist attacks may be sick and not know it; and Sanofi and Google team up for a diabetes venture.

September 12th 2016

Dr Scott Breidbart Explains the Concerns With Paying for Adherence

Scott Breidbart, MD, MBA, chief clinical officer of EmblemHealth, explained that paying patients for adherence could be efficient when the payment initiatives are targeted towards members who have not shown to be adherent; however, he added that there are several limitations in paying for adherence, including the sustainability of the system and whether it will incentivize patients who are adherent to stop taking their medications.

September 10th 2016

This Week in Managed Care: September 10, 2016

This week, the top stories in managed care were poll results that show Hillary Clinton is more trusted than Donald Trump when it comes to healthcare, multiple studies highlighting remaining disparities in healthcare, and results of a digital diabetes self-management program.

September 10th 2016

Millennials Show Improved Health, Well-Being Compared With Older Generations

Laura Joszt, MA

Millennials are one of the few bright spots in American well-being. According to Gallup, millennials in the United States have a lower obesity rate compared with older generations, and millennials have actually seen their obesity rate go down since 2008.

September 9th 2016

Intensive Diabetes Management Adds Years to Life, Study Finds

Mary Caffrey

A group of patients receiving intensive diabetes management treatment lived 7.9 years longer and had fewer cardiovascular events, the study found.

September 8th 2016

Study Finds Teens Respond to Warning Labels on Soda

Mary Caffrey

The study supports earlier findings that warning labels affect parental choices of beverages for their children.

...

51 52 53 54 55 56 57 58 59

...

99 >

259 Prospect Plains Rd, Bldg H,
Monroe, NJ 08831

Do Not Sell My Information

Terms & Conditions